UBS O'Connor’s Healthcare Services Acquisition Corporation Class A Common Stock HCAR Stock Holding History

UBS O'Connor’s Portfolio HCAR Stock Details HCAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-238,623	Closed	-$2.37M	–	787
2022 Q3	$2.37M	Sell	238,623 -23,888	-9%	-$236K	0.03%	538
2022 Q2	$2.58M	Buy	+262,511	New	+$2.58M	0.03%	534
2022 Q1	–	Sell	-257,885	Closed	-$2.52M	–	647
2021 Q4	$2.52M	Buy	257,885 +6,906	+3%	+$67.5K	0.02%	500
2021 Q3	$2.44M	Buy	+250,979	New	+$2.43M	0.02%	486

UBS O'Connor's HCAR Position: Q4 2022 in Review

UBS O'Connor sold out of Healthcare Services Acquisition Corporation Class A Common Stock (HCAR) in Q4 2022, closing a stake of 238,623 shares — an estimated $2.37M sold.

UBS O'Connor first reported a position in HCAR in Q3 2021 and held it in 4 quarters. The position peaked at $2.58M in Q2 2022. 0 funds tracked by Wall St. Rank hold HCAR as of Q4 2022.

UBS O'Connor reported no remaining Healthcare Services Acquisition Corporation Class A Common Stock position as of Q4 2022 after selling out during the quarter.
UBS O'Connor sold 238,623 Healthcare Services Acquisition Corporation Class A Common Stock shares in Q4 2022, an estimated $2.37M.
UBS O'Connor first reported a position in Healthcare Services Acquisition Corporation Class A Common Stock in Q3 2021 and held it in 4 quarters.
UBS O'Connor's Healthcare Services Acquisition Corporation Class A Common Stock position peaked at $2.58M in Q2 2022.
0 funds tracked by Wall St. Rank held Healthcare Services Acquisition Corporation Class A Common Stock as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.